Science policy news weekly roundup: June 3, 2016

If you find a particularly interesting article, please send it to aporter@asbmb.org for inclusion in next week’s roundup.

 

Congress adjourned in observance of Memorial Day on Monday, May 30. Later in the week lawmakers on both sides of the aisle pushed for votes on funding. The biomedical research community is bracing for the impact that Zika funding may have.

During this week’s recess, Senator Marco Rubio, R-FL, wants congress to hear from voters fearing Zika virus (The Palm Beach Post)

Senate democrats to force vote on Zika funding (The Hill)

Congressional Republicans are playing games with a public-health emergency (The Washington Post)           

Millions in Ebola Funding, a casualty of Zika Virus, may not be replenished (Stat)

A day after Zika ‘epidemic’ hearing, Congress shuts down for two weeks without taking action   (KeysInfoNet)

Local health departments brace for funding loss amid Zika standoff (The Hill)

 

Concerns, as well as support, rise from national initiatives that impact the biomedical research enterprise.

National Cancer Moonshot has lofty goal (Stamford advocate)

FDA Commissioner Califf highlights key concerns for 21st Century Cures Act (mondaq)

Nation must invest in scientific research to cure the incurable  (Buffalo News)

Will Senate COMPETES bill narrow partisan gap in congress over U.S. research policy? (Science

Magazine)

New overtime rules are good for postdocs – and the missions of their universities  (MinnPost)

 

Seattle mayor negotiates international partnership that will support biomedical research collaborations between the city of Seattle and the city of Shenzhen in China.

Seattle mayor signs trade, research agreements on China trip  (Seattle Times)

Leave a Reply

Your email address will not be published. Required fields are marked *